PDGFRB and Lynch syndrome: Unlike other cancer predisposition syndromes such as Lynch Syndrome, some of the germline mutations that result in inherited GIST, such as mutations involving KIT and PDGFR genes, produce abnormal proteins that can be inhibited by currently available targeted therapy.